메뉴 건너뛰기




Volumn 75, Issue 1, 2014, Pages 543-552

A randomized clinical trial of high-dosage coenzyme Q10 in early parkinson disease no evidence of benefit

(191)  Flint Beal, M a   Oakes, David b   Shoulson, Ira c   Henchcliffe, Claire a   Galpern, Wendy R d   Haas, Richard e   Juncos, Jorge L f   Nutt, John G g   Voss, Tiffini Smith h   Ravina, Bernard i   Shults, Clifford M e,j   Helles, Karen b   Snively, Victoria b   Lew, Mark F k   Griebner, Brian b   Watts, Arthur b   Gao, Shan b   Pourcher, Emmanuelle l   Bond, Louisette l   Kompoliti, Katie m   more..


Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; UBIDECARENONE;

EID: 84900479240     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.131     Document Type: Article
Times cited : (302)

References (28)
  • 1
    • 33846572874 scopus 로고    scopus 로고
    • Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
    • Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384-386.
    • (2007) Neurology , vol.68 , Issue.5 , pp. 384-386
    • Dorsey, E.R.1    Constantinescu, R.2    Thompson, J.P.3
  • 2
    • 77953425159 scopus 로고    scopus 로고
    • Mitochondrial therapies for Parkinson’s disease
    • Thomas B, Beal MF.Mitochondrial therapies for Parkinson’s disease. Mov Disord. 2010;25(suppl 1):S155-S160.
    • (2010) Mov Disord , vol.25 , pp. S155-S160
    • Thomas, B.1    Beal, M.F.2
  • 3
    • 71849091967 scopus 로고    scopus 로고
    • Therapeutic approaches to mitochondrial dysfunction in Parkinson’s disease
    • Beal MF. Therapeutic approaches to mitochondrial dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(suppl 3):S189-S194.
    • (2009) Parkinsonism Relat Disord , vol.15 , pp. S189-S194
    • Beal, M.F.1
  • 5
    • 20444365828 scopus 로고    scopus 로고
    • Therapeutic role of coenzyme Q(10) in Parkinson’s disease
    • Shults CW. Therapeutic role of coenzyme Q(10) in Parkinson’s disease. Pharmacol Ther. 2005;107(1):120-130.
    • (2005) Pharmacol Ther , vol.107 , Issue.1 , pp. 120-130
    • Shults, C.W.1
  • 6
    • 0030612117 scopus 로고    scopus 로고
    • Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
    • Shults CW, Haas RH, Passov D, Beal MF. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol. 1997;42(2):261-264.
    • (1997) Ann Neurol , vol.42 , Issue.2 , pp. 261-264
    • Shults, C.W.1    Haas, R.H.2    Passov, D.3    Beal, M.F.4
  • 8
    • 0031044805 scopus 로고    scopus 로고
    • Energy metabolism defects in Huntington’s disease and effects of coenzyme Q10
    • Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington’s disease and effects of coenzyme Q10. Ann Neurol. 1997;41(2):160-165.
    • (1997) Ann Neurol , vol.41 , Issue.2 , pp. 160-165
    • Koroshetz, W.J.1    Jenkins, B.G.2    Rosen, B.R.3    Beal, M.F.4
  • 9
    • 56049088295 scopus 로고    scopus 로고
    • Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: Predictor of efficacy of vitamin E and coenzyme Q10 therapy
    • Cooper JM, Korlipara LV, Hart PE, Bradley JL, Schapira AH. Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol. 2008;15(12):1371-1379.
    • (2008) Eur J Neurol , vol.15 , Issue.12 , pp. 1371-1379
    • Cooper, J.M.1    Korlipara, L.V.2    Hart, P.E.3    Bradley, J.L.4    Schapira, A.H.5
  • 10
    • 49249087500 scopus 로고    scopus 로고
    • Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial
    • Stamelou M, Reuss A, Pilatus U, et al. Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord. 2008;23(7):942-949.
    • (2008) Mov Disord , vol.23 , Issue.7 , pp. 942-949
    • Stamelou, M.1    Reuss, A.2    Pilatus, U.3
  • 11
    • 0036771852 scopus 로고    scopus 로고
    • Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline
    • Shults CW, Oakes D, Kieburtz K, et al; Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59(10):1541-1550.
    • (2002) Arch Neurol , vol.59 , Issue.10 , pp. 1541-1550
    • Shults, C.W.1    Oakes, D.2    Kieburtz, K.3
  • 12
    • 34447252358 scopus 로고    scopus 로고
    • German Coenzyme Q(10) Study Group. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease
    • Storch A, Jost WH, Vieregge P, et al; German Coenzyme Q(10) Study Group. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007;64(7): 938-944.
    • (2007) Arch Neurol , vol.64 , Issue.7 , pp. 938-944
    • Storch, A.1    Jost, W.H.2    Vieregge, P.3
  • 13
    • 0000224448 scopus 로고
    • Members of the UPDRS Development Committee
    • In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds, Florham Park, NJ: Macmillan Healthcare Information
    • Fahn S, Elton R; Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson’s Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information;1987:153-163.
    • (1987) Recent Developments in Parkinson’s Disease , vol.2 , pp. 153-163
    • Fahn, S.1    Elton, R.2
  • 14
    • 0016823810 scopus 로고
    • Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
    • (1975) J Psychiatr Res , vol.12 , Issue.3 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 15
    • 35148882113 scopus 로고    scopus 로고
    • Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
    • Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology. 2007;69(15):1480-1490.
    • (2007) Neurology , vol.69 , Issue.15 , pp. 1480-1490
  • 16
    • 3042717908 scopus 로고    scopus 로고
    • Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson’s disease
    • Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson’s disease. Exp Neurol. 2004;188(2):491-494.
    • (2004) Exp Neurol , vol.188 , Issue.2 , pp. 491-494
    • Shults, C.W.1    Flint Beal, M.2    Song, D.3    Fontaine, D.4
  • 17
    • 33846115045 scopus 로고    scopus 로고
    • A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
    • NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 2007;68(1):20-28.
    • (2007) Neurology , vol.68 , Issue.1 , pp. 20-28
  • 18
    • 77955792985 scopus 로고    scopus 로고
    • Protect Study Group. A double-blind, placebo-controlled study to assess themitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson’s disease
    • Snow BJ, Rolfe FL, Lockhart MM, et al; Protect Study Group. A double-blind, placebo-controlled study to assess themitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson’s disease. Mov Disord. 2010;25(11):1670-1674.
    • (2010) Mov Disord , vol.25 , Issue.11 , pp. 1670-1674
    • Snow, B.J.1    Rolfe, F.L.2    Lockhart, M.M.3
  • 19
    • 79959242100 scopus 로고    scopus 로고
    • Mitochondrial contribution to Parkinson’s disease pathogenesis
    • Schapira AH, Gegg M. Mitochondrial contribution to Parkinson’s disease pathogenesis. Parkinsons Dis. 2011;2011:159160.
    • (2011) Parkinsons Dis , vol.2011 , pp. 159160
    • Schapira, A.H.1    Gegg, M.2
  • 20
    • 55849122639 scopus 로고    scopus 로고
    • Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
    • Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008;4(11):600-609.
    • (2008) Nat Clin Pract Neurol , vol.4 , Issue.11 , pp. 600-609
    • Henchcliffe, C.1    Beal, M.F.2
  • 21
    • 77952673222 scopus 로고    scopus 로고
    • Coenzyme Q10 in human blood: Native levels and determinants of oxidation during processing and storage
    • Franke AA, Morrison CM, Bakke JL, Custer LJ, Li X, Cooney RV. Coenzyme Q10 in human blood: native levels and determinants of oxidation during processing and storage. Free Radic Biol Med. 2010;48(12):1610-1617.
    • (2010) Free Radic Biol Med , vol.48 , Issue.12 , pp. 1610-1617
    • Franke, A.A.1    Morrison, C.M.2    Bakke, J.L.3    Custer, L.J.4    Li, X.5    Cooney, R.V.6
  • 22
    • 34248162014 scopus 로고    scopus 로고
    • Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
    • Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7(suppl): S78-S88.
    • (2007) Mitochondrion , vol.7 , pp. S78-S88
    • Bhagavan, H.N.1    Chopra, R.K.2
  • 23
    • 34248170185 scopus 로고    scopus 로고
    • Coenzyme Q10 and statins: Biochemical and clinical implications
    • Littarru GP, Langsjoen P. Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion. 2007;7(suppl):S168-S174.
    • (2007) Mitochondrion , vol.7 , pp. S168-S174
    • Littarru, G.P.1    Langsjoen, P.2
  • 24
    • 23644449049 scopus 로고    scopus 로고
    • Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons
    • Wang XL, Rainwater DL, Mahaney MC, Stocker R. Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr. 2004;80(3):649-655.
    • (2004) Am J Clin Nutr , vol.80 , Issue.3 , pp. 649-655
    • Wang, X.L.1    Rainwater, D.L.2    Mahaney, M.C.3    Stocker, R.4
  • 25
    • 13844298846 scopus 로고    scopus 로고
    • Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice
    • McDonald SR, Sohal RS, Forster MJ. Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice. Free Radic Biol Med. 2005;38(6):729-736.
    • (2005) Free Radic Biol Med , vol.38 , Issue.6 , pp. 729-736
    • McDonald, S.R.1    Sohal, R.S.2    Forster, M.J.3
  • 26
    • 84859856337 scopus 로고    scopus 로고
    • Motor signs in the prodromal phase of Parkinson’s disease
    • Maetzler W, Hausdorff JM. Motor signs in the prodromal phase of Parkinson’s disease. Mov Disord. 2012;27(5):627-633.
    • (2012) Mov Disord , vol.27 , Issue.5 , pp. 627-633
    • Maetzler, W.1    Hausdorff, J.M.2
  • 27
    • 73949157929 scopus 로고    scopus 로고
    • Parkinson Study Group DATATOP and PRECEPT investigators. A comparison of treatment thresholds in two large Parkinson’s disease clinical trial cohorts
    • Marras C, Lang AE, Eberly SW, et al; Parkinson Study Group DATATOP and PRECEPT investigators. A comparison of treatment thresholds in two large Parkinson’s disease clinical trial cohorts. Mov Disord. 2009;24(16):2370-2378.
    • (2009) Mov Disord , vol.24 , Issue.16 , pp. 2370-2378
    • Marras, C.1    Lang, A.E.2    Eberly, S.W.3
  • 28
    • 85009226418 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease
    • Huntington Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology. 2001;57(3):397-404.
    • (2001) Neurology , vol.57 , Issue.3 , pp. 397-404


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.